Ardelyx Inc (NASDAQ:ARDX) has a beta value of 0.83 and has seen 7.38 million shares traded in the last trading session. The company, currently valued at $1.10B, closed the last trade at $4.66 per share which meant it lost -$0.73 on the day or -13.54% during that session. The ARDX stock price is -117.38% off its 52-week high price of $10.13 and 6.87% above the 52-week low of $4.34. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.15 million shares traded. The 3-month trading volume is 4.02 million shares.
The consensus among analysts is that Ardelyx Inc (ARDX) is Buy stock at the moment, with a recommendation rating of 1.40. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 8 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ardelyx Inc (NASDAQ:ARDX) trade information
Sporting -13.54% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ARDX stock price touched $4.66 or saw a rise of 14.81%. Year-to-date, Ardelyx Inc shares have moved -24.84%, while the 5-day performance has seen it change -11.57%. Over the past 30 days, the shares of Ardelyx Inc (NASDAQ:ARDX) have changed -6.24%. Short interest in the company has seen 24.32 million shares shorted with days to cover at 4.32.
Wall Street analysts have a consensus price target for the stock at $11, which means that the shares’ value could jump 57.64% from current levels. The projected low price target is $11.0 while the price target rests at a high of $11.0. In that case, then, we find that the current price level is -136.05% off the targeted high while a plunge would see the stock gain -136.05% from current levels.
Ardelyx Inc (ARDX) estimates and forecasts
Figures show that Ardelyx Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -21.68% over the past 6 months, with this year growth rate of 40.00%, compared to 16.50% for the industry. Revenue growth from the last financial year stood is estimated to be 161.98%.
10 analysts offering their estimates for the company have set an average revenue estimate of 108.57M for the current quarter. 7 have an estimated revenue figure of 83.33M for the next ending quarter. Year-ago sales stood 34.36M and 46.02M respectively for this quarter and the next, and analysts expect sales will grow by 215.94% for the current quarter and 161.98% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 28.61% over the past 5 years. Earnings growth for 2024 is a modest 41.17% while over the next 5 years, the company’s earnings are expected to increase by 30.00%.
ARDX Dividends
Ardelyx Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Ardelyx Inc (NASDAQ:ARDX)’s Major holders
Insiders own 1.69% of the company shares, while shares held by institutions stand at 61.90% with a share float percentage of 62.97%. Investors are also buoyed by the number of investors in a company, with Ardelyx Inc having a total of 271.0 institutions that hold shares in the company. The top two institutional holders are JANUS HENDERSON GROUP PLC with over 25.95 million shares worth more than $192.14 million. As of 2024-06-30, JANUS HENDERSON GROUP PLC held 11.1339% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 17.55 million shares as of 2024-06-30. The firm’s total holdings are worth over $130.06 million and represent 7.5312% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF . As of Sep 30, 2024 , the former fund manager holds about 2.97% shares in the company for having 7.03 shares of worth $32.78 million while later fund manager owns 6.83 shares of worth $31.84 million as of Sep 30, 2024 , which makes it owner of about 2.88% of company’s outstanding stock.
